Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Glabbeke, M. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(9)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(6)
+
-
Creation Date
2010
(3)
+
-
2011
(3)
+
-
2012
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Topic
Osteosarcoma
(2)
+
-
Survival
(2)
+
-
chemotherapy
(2)
+
-
Author
Glabbeke, M. van
(9)
+
-
Gelderblom, H.
(7)
+
-
Hogendoorn, P.C.W.
(7)
+
-
Hohenberger, P.
(4)
+
-
Jinks, R.C.
(4)
+
-
Lewis, I.J.
(4)
+
-
McTiernan, A.
(4)
+
-
Nooij, M.A.
(4)
+
-
Taminiau, A.H.M.
(4)
+
-
Blay, J.Y.
(3)
+
-
Grimer, R.J.
(3)
+
-
Ouali, M.
(3)
+
-
Bramwell, V.
(2)
+
-
Bramwell, V.H.C.
(2)
+
-
Cesne, A. le
(2)
+
-
European Osteosarcoma Intergrp
(2)
+
-
Hook, J.M.
(2)
+
-
Krarup-Hansen, A.
(2)
+
-
Rutkowski, P.
(2)
+
-
Sciot, R.
(2)
+
-
Sleijfer, S.
(2)
+
-
Sydes, M.
(2)
+
-
Sydes, M.R.
(2)
+
-
Uscinska, B.
(2)
+
-
Verweij, J.
(2)
+
-
Whelan, J.
(2)
+
-
Whelan, J.S.
(2)
+
-
Show more
Language
en
(9)
+
-
Search results
(1 - 9 of 9)
show grid
show list
save search
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials
Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study
DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Tre